Objectives: Peroxisomes play a crucial role in lipid and reactive oxygen species metabolism, but their importance for pancreatic b-cell functioning is presently unknown. To examine the contribution of peroxisomal metabolism to b-cell homeostasis in mice, we inactivated PEX5, the import receptor for peroxisomal matrix proteins, in an inducible and b-cell restricted manner (Rip-Pex5 À/À mice).
INTRODUCTION
Peroxisomes are still enigmatic organelles six decades after their discovery [1] . The foremost metabolic functions of peroxisomes include a-and b-oxidation of fatty acids, synthesis of ether phospholipids, bile acids, and polyunsaturated fatty acids, and detoxification of oxygen radicals and glyoxylate [2] . More recently, it was discovered that peroxisomes also serve as a platform in antiviral signaling [3] , and it is becoming clear that they have multiple interactions with other cellular organelles [4e6] . Whereas the role of peroxisomes has been intensively studied in tissues like liver and brain, their importance for pancreatic b-cell function remains largely unexplored. Intriguingly, pancreatic b-cells are almost devoid of catalase, a key peroxisomal antioxidant marker enzyme [7] , due to islet-selective repression of the catalase gene [8] . Catalase belongs to a small group of 'forbidden' genes, that are thought to be suppressed in order to allow specific b-cell function [9, 10] . However, individual overexpression of the 'disallowed' anti-oxidant enzymes, including catalase, in the cytosol or mitochondria did not impair responsiveness of insulin-secreting cells to glucose, leaving the functional importance of the suppression unresolved [11] . It was further reported that the frequency of diabetes is higher in catalasedeficient patients [12] .
It is widely accepted that, in addition to oxidative stress, b-cells are susceptible to glucolipotoxicity [13] . Besides other mechanisms that were proposed, Lenzen and coworkers showed that H 2 O 2 produced during peroxisomal b-oxidation is the mediator of fatty acid-induced toxicity in b-cells [14] . Treatment of RINm5F rat insulinoma cells and primary rat islets with various saturated fatty acids induced peroxisomal H 2 O 2 production, as detected by peroxisome-targeted HyPer, a genetically encoded H 2 O 2 sensor. Furthermore, the palmitate-induced cytotoxicity in RINm5F cells was rescued by overexpression of catalase in peroxisomes or in the cytosol, but not in mitochondria [14] .
A different perspective on the potential role of peroxisomal b-oxidation in b-cells was provided by a study from Hellemans et al. [15] . These authors showed that palmitate-induced b-cell toxicity was attenuated by the induction of both peroxisomal and mitochondrial b-oxidation using PPARa and retinoid X receptor agonists [15] . This points to a protective role of peroxisomal b-oxidation in insulin-producing cells.
Together, these studies indicate that there are still uncertainties and different opinions about the potential role of peroxisomal metabolism in b-cell functioning. In the present study, we first assessed the abundance of peroxisomes in the endocrine pancreas. Subsequently, we used an in vivo loss-of-function approach to investigate the role of peroxisomes in pancreatic b-cells. Hereto, the import receptor PEX5, necessary for import of nearly all peroxisomal enzymes into the organelle, was targeted in a b-cell-restricted and inducible manner in adult mice resulting in functional peroxisome deficiency in b-cells.
METHODS

Generation of Rip-Pex5
À/À mice b-cell selective Rip-Pex5
À/À mice were generated by mating Pex5
FL/FL mice with tamoxifen-inducible Tg (Ins2-cre/ERT) 1Dam mice commonly known as Rip(rat insulin promotor)-Cre/ER mice [16] To quantify insulin, approximately 50 ml of blood was collected from each mouse before and after 6 and 12 min of glucose injection from the lateral tail vein, followed by separation of plasma and measured using the Crystal Chem ultra-sensitive mouse ELISA kit (Downers Grove, IL, U.S.A.) according to the manufacturer's protocol (but 10 ml instead of 5 ml plasma was used).
Ex vivo insulin release
Islets were isolated using the collagenase perfusion method and glucose-stimulated insulin secretion (GSIS) was performed as described [18, 19] with minor modifications. Briefly, isolated islets were allowed to recover for 3 h in RPMI1640 medium (Gibco, Invitrogen, UK) containing 10% fetal bovine serum and 100-U/mL penicillin-streptomycin at 37 C under a humidified atmosphere of 5% CO 2 and 98% air. For insulin secretion studies, a batch of 50 sizematched islets was pre-incubated in HEPES Krebs buffer (KRBB) solution containing 5 mM glucose and 0.5% BSA for 30 min. Subsequently, islets were incubated consecutively in KRBB with 5 mM glucose for 1 h and in KRBB with 20 mM glucose for 1 h. All steps were performed at 37 C in a tissue culture incubator. The supernatants were collected to measure insulin release and islets were then sonicated for 3 min in acidic ethanol (final concentrations: 75% EtOH, 0.1 N HCl, 1% Triton) for determining total insulin content. Samples were stored at À20 C until further use. Insulin concentrations of these samples were determined using an ultrasensitive mouse insulin ELISA kit (Mercodia, Uppsala, Sweden) according to the manufacturer's protocol. The stimulation index is represented as the ratio of insulin secreted in response to high glucose versus insulin secreted under low glucose conditions [20] .
Total pancreatic insulin content
Pancreata were dissected, and their weights were recorded. They were put into 5 ml cold (À20 C) acidic ethanol (75% ethanol, 0.1 N HCl). After sonication (Soniprep 150, MSE, London, UK) for 2 min on ice, the homogenates were stored at À20 C overnight. The next day the homogenates were spun at 3000 rpm for 10 min and the supernatants were collected for analysis of insulin content using the Crystal Chem ultra-sensitive mouse ELISA kit (Downers Grove, IL, U.S.A.) according to the manufacturer's protocol.
Immunohistochemical staining and morphometric analysis
Mice were anesthetized with a mix of Dormitor (1 mg/kg) and Nimatek (75 mg/kg) and subsequently perfused transcardially with PBS (pH 7.4) followed by 4% paraformaldehyde (PFA). Pancreata were isolated, post-fixed with 4% PFA overnight, and kept in 70% ethanol prior to paraffin embedding and sectioning (7 mm). The paraffin sections were deparaffinized and rehydrated using routine protocols. Sections were then treated with citrate buffer in a microwave oven to expose the antigenic sites. Blocking was done using (Table 1) . For insulin single staining, sections were incubated overnight at 4 C with the primary antibody followed by 1 h incubation with anti-mouse IgG HRP (Agilent, Burlingame, CA, USA). The TSA Cyanine 3 system (Perkin Elmer) was used for detection and nuclei were visualized with DAPI included in the mounting medium (Agilent). For double immunolabeling, the staining, which was detected with anti-rabbit IgG HRP (Agilent) and the TSA-Plus Fluorescein System (Perkin Elmer), was done first. To examine apoptotic cells, terminal deoxynucleotidyltransferase-mediated dUTP nick end labeling (Roche Applied Science, Indianapolis, IN, USA) was performed according to the manufacturer's protocol. These stainings were followed by insulin staining as described above.
For morphometric analysis, six sections separated by 200 mm were taken throughout the length of the pancreas and stained for insulin.
Quantification of b-cell mass and islet size was done as described [23] . To quantify b-cell proliferation and apoptotic cell death, images of insulin-positive cells (20e25 islets per mouse; n ¼ 5 per genotype) that stained with either Ki67 or TUNEL were captured and the percentage of proliferating or apoptotic cells was determined by counting the Ki67/TUNEL-positive nuclei among 150e300 b-cells per islet.
Images for PEX14/ACAA1-stained sections were acquired using a Zeiss LSM 780 confocal microscope (Carl Zeiss, Munich, Germany), whereas other stainings were quantitatively assessed using a motorized inverted IX-81 microscope connected to a CCD-FV2T digital camera (Olympus, Aartselaar, Belgium).
Electron microscopy
The ultrastructure of pancreatic b-cells was examined using JEM1400 (JEOL) transmission electron microscopy (TEM). Briefly, mice were perfused with and subsequently, pancreas fragments were immersed in 2.5% glutaraldehyde buffered with 0.05 M Nacacodylate buffer (pH 7.3) for 24 h. Prior to embedding in Agar 100 resin, samples were post-fixed in 2% osmium tetroxide (buffered with 0.05 M sodium cacodylate, pH 7.3) and dehydrated using acetone. After dehydration, ultrathin sections were prepared using a Reichert Jung Ultracut E microtome and stained with 0.1% thionin e 0.1% methylene blue. Ultrathin (AE70 nm) sections were mounted on copper grids and stained with uranyl acetate and lead citrate before imaging. To quantify the number of altered mitochondria according to criteria described previously [24] , the data obtained from a minimum 2.7. Complex 1 enzyme activity measurement Isolated islets were homogenized in extraction buffer and lysates (corresponding to 20 mg of proteins) were used to determine the complex I activity using the complex I enzyme activity dipstick assay kit (Abcam, Cambridge, UK) according to the manufacturer's protocol. Measurement of the protein concentration in cell lysates was performed using the Pierce BCA protein kit (Thermo Scientific, Rockford, IL, USA). Signals on the dipsticks were visualized using the ChemiDoc MP system (Bio-Rad; California, USA) and signal intensities were quantified with Image Lab software (Bio-Rad; California, USA).
Biochemical analyses
For C26:0-lysophosphatidylcholine (LPC) analysis, 150e300 islets were suspended in 400 ml PBS and homogenized by sonication. Fifty ml of each sample was set aside for protein determination, the rest was processed as described [25] . For plasmalogen analysis, 120e300 islets were extracted as described [26] , and lipid extracts were analyzed for phospholipids [26] and plasmalogens. For the latter, acid-released aldehydes were derivatized into fluorescent decahydroacridine derivatives (adapted from [27] ), which were separated by RP-HPLC (Waters Symmetry C18, 5 mm, 100 Å, 4.6 Â 150 mm column) and monitored by fluorescence (Waters 2475 Multi-wavelength Fluodetector; ex 390 nm/em 460 nm) (Van Veldhoven P.P., unpublished data). Values were normalized to the phospholipid content of the extracts. For western blotting, 150e200 islets were washed with ice-cold PBS and then lysed with buffer containing 50 mM Tris (pH 8), 150 mM NaCl, 1% NP40, and 1 mM EDTA. PEX5 [28] and ACAA1 [22] were detected using polyclonal rabbit antibodies in combination with HRP-labeled secondary antibodies and the ECL plus detection kit (GE Healthcare, Buckinghamshire, UK).
2.9. RNA sequencing and bioinformatics analysis RNA was extracted from freshly isolated islets of HFD-fed control and Rip-Pex5 À/À mice using the PureLinkÒ RNA Mini Kit (ThermoFisher Scientific, Waltham, MA) following the manufacturer's protocol. RNA integrity was verified on the Agilent Bioanalyser (Agilent, Santa Clara, CA, USA) with the RNA nanochip. The RNA-seq libraries were prepared using the Illumina TruSeq RNA sample preparation kit following the manufacturer's instructions. After library construction, all libraries were quantified, pooled and sequenced on an Illumina NextSeq 500 platform using a 50 bp single-end protocol. After alignment of the sequencing reads to the mouse genome, quantification of transcript abundances was performed using the Kallisto software [29] . We performed a trimmed mean of M-values (TMM)-normalization using the R-package EdgeR [30] and normalization using Limma before down-stream differential analysis. Gene set enrichment analysis (GSEA) against the KEGG database was used to analyze pathway enrichment.
Statistical analyses
Statistical analyses were done using GraphPad Prism 5.01 software. Depending on the experimental design, statistical significance was determined by performing either unpaired t-test or one-way ANOVA followed by the Bonferroni test. Data are expressed as mean AE SEM. P < 0.05 was considered statistically significant.
RESULTS
Peroxisomes are abundant in the endocrine pancreas
Because of the low expression of catalase, the traditional peroxisomal marker enzyme, in pancreatic b-cells [7] , we visualized peroxisomes in mouse whole pancreas sections by immunohistochemical staining using antibodies to PEX14, an essential peroxisomal membrane protein. Co-staining with insulin revealed that PEX14 immunoreactivity was markedly higher in the endocrine than in the exocrine pancreas ( Figure 1A ), pointing to an important function of peroxisomes in islets.
Likewise, the peroxisomal b-oxidation enzyme ACAA1 was more abundantly expressed in islets, including b-cells, as compared to the surrounding cells ( Figure 1A ), which is indicative of an active peroxisomal b-oxidation pathway in insulin-producing cells. This observation raised our interest to understand how peroxisomes contribute to the functioning of b-cells.
Generation and validation of
We generated a tamoxifen-inducible b-cell-specific Pex5 knockout mouse model using Rat insulin promotor (Rip)-Cre/ER mice [16] . The efficiency of Pex5 deletion in pancreatic islets isolated from control and Rip-Pex5 À/À mice was studied two weeks after tamoxifen induction by immunoblotting. PEX5 immunoreactivity was strongly reduced in islets of Rip-Pex5 À/À as compared to control mice ( Figure 1B ). This resulted in impaired PEX5 function as evidenced by the presence of the 44 kDa precursor of ACAA1, whereas control islets contained the mature 41 kDa protein, which is known to be generated after import into peroxisomes ( Figure 1B ). The residual PEX5 immunoreactivity and peroxisomal import activity in Rip-Pex5 À/À islets can be attributed to unaffected PEX5 in non-b-cells of the islets, although incomplete inactivation of PEX5 in b-cells cannot be excluded. We subsequently examined whether the loss of functional peroxisomes had an impact on peroxisomal metabolites in isolated islets. Levels of C26:0-LPC, a sensitive marker for impaired peroxisomal b-oxidation [31, 32] , were 5-fold increased ( Figure 1C ), and plasmalogen levels were reduced by w35%, pointing to decreased ether lipid synthesis activity ( Figure 1D ).
Together, these data indicate that inactivation of the Pex5 gene in bcells of Rip-Pex5 À/À mice was successful.
Glucose tolerance and insulin secretion is impaired in
We then assessed the consequences of peroxisome inactivation on bcell functioning in mice either fed normal chow or a HFD diet for a period of 12 weeks, starting one week after the last tamoxifen injection. Body weights of Rip-Pex5 À/À mice were not significantly different from control mice on either diet (Figure 2A and D) . However, the blood glucose levels were significantly elevated in Rip-Pex5 À/À mice on either diet, in the fed ( Figure 2B and E) as well as in the fasted state ( Figure 2C and F), indicative of impaired glucose homeostasis. To further assess glucose tolerance, an IPGTT was performed. As expected, HFD feeding induced metabolic stress in both genotypes as evident from an increased AUC ( Figure 2H ) as compared to the respective genotype on chow diet ( Figure 2G ). Glucose tolerance was significantly impaired in Rip-Pex5 À/À mice on both diets, with a significant increase in AUC as compared to their respective controls ( Figure 2G, H) . It was previously shown that several pancreas-specific Cre driver lines exhibit islet dysfunction and impaired insulin secretion, even in the absence of genes targeted by loxP sites [17, 23] . Figure 1; data not shown). This excluded the role of the CRE/ER fusion protein in the observed phenotype, and therefore, Rip-Pex5 À/À mice were compared with Pex5 FL/FL mice in all subsequent studies. Next, we assessed whether the impaired glucose homeostasis in RipPex5 À/À mice was related to abnormal plasma insulin levels in the samples collected just before starting the IPGTT as well as after 6 and 12 min of glucose injection. Control mice on either diet responded physiologically with higher circulating insulin, whereas Rip-Pex5
À/À mice were unable to do so although a significant difference with controls was observed only upon high-fat feeding ( Figure 3A, B) . Although it is most likely that impaired glucose homeostasis in RipPex5 Furthermore, the total pancreatic insulin content was measured using ELISA. Rip-Pex5 À/À mice contained significantly lower levels of total pancreatic insulin compared to controls on both diets ( Figure 3E ). To further assess whether the reduced pancreatic insulin content is were differentially expressed in Rip-Pex5 À/À mice. In the entire set of differentially expressed genes (DEGs), many B-cell specific genes were represented such as immunoglobulin heavy and kappa variable fragments, and these were considered irrelevant. However, we identified a limited number of genes that are of interest ( Figure 4C ). The dramatic upregulation of the Esr1 gene was likely due to the presence of the estrogen receptor in the transgenic Cre/ER construct. Interestingly, Vnn1, an enzyme important in maintaining islet cell homeostasis [44] , was also significantly down-regulated in Rip-Pex5 À/À mice as compared to controls ( Figure 4C ). Together these results suggest that loss of functional peroxisomes impacts on b-cell survival. In addition, a significant increase in mRNA levels of voltage-dependent potassium channels and chemokines was observed (Supplementary Figure 3) . Because pathway analysis can reveal more marginal expression changes of the constituent genes, we applied GSEA using the KEGG database. Enrichment analysis of DEGs in the functional class of cellular processes revealed that genes were primarily enriched in "phagosome", "p53 signaling" and 'lysosome' pathways ( Figure 4D ).
To validate the gene expression data, we first performed immunofluorescence staining of pancreatic sections to evaluate the extent of proliferation and apoptosis of b-cells in Rip-Pex5
À/À mice. Double stainings of insulin were performed with either the proliferation marker
Ki-67 or with the TUNEL assay to assess b-cell apoptosis. As shown in Figure 5A , the percentage of TUNEL-positive b-cells was significantly increased in Rip-Pex5 À/À mice as compared to control mice. In contrast, no significant differences were observed in the number of proliferating b-cells between the groups ( Figure 5B ). To exclude the possibility that the observed increase in apoptosis is merely caused by hyperglycemia, the TUNEL assay was performed at an earlier age, 2 weeks after the last tamoxifen injection. These Rip-Pex5 À/À mice also exhibited increased b-cell apoptosis in comparison to control mice (Supplementary Figure 5) . Thus, the changes in b-cells antedate the onset of hyperglycemia and are likely a cause, rather than a consequence of it. To evaluate the upregulated 'lysosome' pathway, we stained with LAMP2 antibodies. Rip-Pex5 À/À islets stained clearly stronger for LAMP2, indicative of increased lysosomal activity ( Figure 6C ). Interestingly, the cells exhibiting higher LAMP2 fluorescence displayed low but detectable insulin levels ( Figure 6B ). Finally, in view of the role of peroxisomes in ROS metabolism [45] , it is interesting to note that the RNAseq data did not indicate a deregulation of ROS signaling pathways. This was further confirmed by unaltered staining of 4-HNE (Supplementary Figure 4) , a marker for increased oxidative stress [46] . 
DISCUSSION
Peroxisomes are dynamic organelles with considerable structural and biochemical plasticity that adapt their content to cellular and environmental demands [1] . Despite decades of research, however, their specific role for the functioning of diverse cell types is still largely obscure. Here, we show that deletion of functional peroxisomes from b-cells through impeding the import of matrix proteins disrupts b-cell structure and function. 
Original Article
In comparison to the exocrine pancreas, we found that the abundance of peroxisomes in islets was very high, pointing to particular roles of these organelles in the endocrine cells. This is likely not related to an anti-oxidant function as it is well established that catalase expression in b-and a-cells is notoriously low [47] . Catalase is indeed one of the 'forbidden' genes [9, 48] in mouse pancreatic islet tissue but the significance of this profound repression of mRNA abundance for b-cell functioning is not clear. Lentiviralmediated overexpression of catalase, either in the cytosol or in mitochondria, did not affect glucose-stimulated insulin secretion in rat islets [11] . However, elevating the levels of catalase in its normal cellular context i.e. in peroxisomes was not attempted. The precise role of ROS signaling for b-cell function has still not been elucidated.
According to data from Elsner et al. [14] , the production of peroxisomal H 2 O 2 , a side product formed during the first step of peroxisomal b-oxidation, is toxic for rat b-cells. Differences between saturated and unsaturated fatty acids [49] and between rat and human [50] were subsequently reported, which cannot be explained by our current understanding of peroxisomal b-oxidation. Peroxisomes play a pivotal role in cellular ROS homeostasis, but the consequences of the ectopic localization of both the ROS generating and degrading enzymes are unpredictable and could depend on the cell type. In Rip-Pex5
À/À mice, we did not find evidence for increased ROS and it is therefore unlikely that aberrant redox signaling is responsible for the observed phenotype. Instead, the high peroxisomal abundance in b-cells and the cellular aberrations caused by their absence are probably related to the role of peroxisomes in lipid metabolism. Deletion of peroxisomal matrix import protein resulted both in increased levels of very long chain fatty acids due to a defect in b-oxidation and in a reduction of plasmalogens due to impaired ether lipid synthesis. Which of these or possibly other metabolic derangements contribute to the observed phenotype remains to be investigated. In this respect, it is interesting to note that a mild reduction in phoshatidylcholine plasmalogen species, but not in the more abundant phosphatidylethanolamine plasmalogens, was found following stimulation of murine pancreatic islets with glucose [52] .
The most prominent alterations in b-cells were degenerative features of mitochondria and an accumulation of vacuole-like structures. Mitochondrial alterations as a consequence of defective peroxisomal function were previously reported but were strongly dependent on the cell type and nature of the peroxisomal dysfunction. Mitochondrial destruction was most prominent in Pex5-deficient hepatocytes, with sparse and unusually shaped cristae and a severe reduction of complex I activity [51] . Other complexes were less (complex III and V) or not affected (complex II and IV) [51] . In contrast no obvious functional nor structural mitochondrial impairments were seen in Pex5-deleted striated muscle and brain [53] . In Pex5-deficient b-cells, several mitochondria were found in which the cristae structure seemed to be gradually lost, ultimately impacting complex I activity. In addition, in the majority but not in all b-cells, an accumulation of vesicles with a low electron density and surrounded by a single membrane was observed. Such structures were not seen in other Pex5-deficient cell types (hepatocytes, neural cells, striated muscle) [51, 53] . We could not define the origin and nature of these vacuole-like structures but in view of their size, they are not compatible with peroxisomal ghosts [54] . Cytoplasmic vacuolization, a well-known morphological phenomenon observed in mammalian cells in response to viral or toxic inducers, has been implicated in various forms of cell death [55] . Vacuoles can originate from several components of the endo-lysosomal system.
Interestingly, such structures of undefined origin were also seen in b- The b-cell deregulation could be a direct consequence of altered levels of peroxisomal metabolites, but the secondary cellular alterations, and in particular the degeneration of an important fraction of mitochondria, could be involved as well. In order to decipher how the loss of peroxisomal activity in b-cells interferes with other cellular compartments, including mitochondria and the endolysosomal system, and results in increased apoptotic cell death, it would be instructive to eliminate PEX5 in an insulinoma cell line. Provided that the cellular anomalies are recapitulated in vitro, this would allow to define the sequence of cellular events and to stimulate or block processes, such as the endolysosomal pathway. It also remains to be investigated whether the findings in mice can be translated to men. In patients with peroxisome biogenesis disorders, glucose homeostasis has not been well documented. Severely affected patients have feeding difficulties due to hypotonia and usually do not live up to one year of age, hence they are not exposed to lipid overload. On the other hand, the longer-surviving patients have mild mutations which may not lead to b-cell dysfunction. Ageing has been related to reduced peroxisomal function, and it remains to be investigated whether this could impact on b-cell function, in particular in conditions of metabolic overload.
CONCLUSIONS
In conclusion, this study was performed in response to long-standing open questions on how peroxisomes contribute to b-cell function. Our data provide evidence that peroxisomal metabolism plays an essential role in the preservation of b-cell integrity. Although we cannot exclude the involvement of other cell types, this likely occurs in a cell autonomous way. This suggests that enhancing peroxisome activity is a potential avenue to support b-cell function in metabolic stress conditions.
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